Accutane pulled from U.S. market

Case Review Form

* Denotes required field.

Title

* First Name

* Last Name

* Email Address

* Phone Number

Cell Phone Number

Office Phone Number

Street Address

Apartment/Suite

City

State

Zip Code

Please provide the best method and times to contact you:

Date of birth of injured person
(mm-dd-yyyy):

Name of drug:

Date you started taking the drug (mm-yyyy):

Date you stopped taking the drug (mm-yyyy):

Please describe any side effects:

Other Info:

No Yes, I agree to the Parker & Waichman, LLP disclaimers.Click here to review all.

Yes, I would like to receive the Parker & Waichman, LLP monthly newsletter, InjuryAlert.

Accutane pulled from U.S. market

June 29th, 2009 joshua

Roche Holding AG has pulled its acne medication, Accutane, from the U.S. market after numerous reports of it being linked to a bowel disease.

According to a Bloomberg News report, Roche informed the Food and Drug Administration that it was pulling Accutane from the market because it feared too much competition from generics.

More than 5,000 claims against Roche have been made in relation to Accutane. People taking the drug claim they weren’t properly warned of the dangers of it causing inflammatory bowel disease.

One attorney interviewed by Bloomberg said he’s won $10.5 million from Roche in cases he’s presented against Accutane and believes there will be more cases in the face of this recent development.

At least 13 million people have taken Accutane since it was introduced to the U.S. market in 1982.

Share and Enjoy: These icons link to social bookmarking sites where readers can share and discover new web pages.